STAGE IV RENAL CELL CANCER AJCC V8
Clinical trials for STAGE IV RENAL CELL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV RENAL CELL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV RENAL CELL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo for tough kidney cancer shows promise but study halted early
Disease control TerminatedThis study tested a combination of two drugs, sitravatinib and nivolumab, in 15 adults with advanced clear cell kidney cancer that had worsened after previous treatments. The goal was to see if the combination could shrink tumors or slow the disease. The trial was stopped early, …
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:39 UTC
-
Immunotherapy combo studied for rare kidney cancer, but trial stopped early
Disease control TerminatedThis study tested two immunotherapy drugs, nivolumab and ipilimumab, in 10 people with a rare and aggressive kidney cancer called renal medullary carcinoma. The goal was to see if the combination could shrink tumors or slow cancer growth. The trial was terminated early, so result…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:26 UTC
-
Experimental combo aims to reboot immune attack on tough cancers
Disease control TerminatedThis early-phase study tested a drug called plinabulin combined with radiation and immunotherapy in 19 people with advanced cancers (like lung, bladder, or melanoma) that had stopped responding to standard immunotherapy. The goal was to see if the combination was safe and could s…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
Immunotherapy before kidney surgery shows promise in small trial
Disease control TerminatedThis study tested giving pembrolizumab (with or without axitinib) before surgery to people with advanced kidney cancer that had spread. The goal was to see if this approach could boost the immune system's attack on the tumor and help control the cancer better than surgery alone. …
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC